Search Results

SB 415286 10mg 10mg  | Purity Not Available

Adooq Bioscience

SB 415286 is a potent and selective cell-permeable, ATP-competitive inhibitor of GSK3?? with an IC50 value of 78 nM (similar potency for GSK3??) and a Ki value of 31 nM.

More Information Supplier Page

CX-4945 (Silmitasertib) 50mg 50mg  | Purity Not Available

Adooq Bioscience

CX-4945 is a potent and selective orally bioavailable small molecule inhibitor of CK2 that inhibits human umbilical vein endothelial cell migration, tube formation, and blocks CK2-dependent hypoxia-induced factor 1 alpha (HIF-1??) transcription in cancer cells.

More Information Supplier Page

CX-4945 (Silmitasertib) 5mg 5mg  | Purity Not Available

Adooq Bioscience

CX-4945 is a potent and selective orally bioavailable small molecule inhibitor of CK2 that inhibits human umbilical vein endothelial cell migration, tube formation, and blocks CK2-dependent hypoxia-induced factor 1 alpha (HIF-1??) transcription in cancer cells.

More Information Supplier Page

CX-4945 (Silmitasertib) 2mg 2mg  | Purity Not Available

Adooq Bioscience

CX-4945 is a potent and selective orally bioavailable small molecule inhibitor of CK2 that inhibits human umbilical vein endothelial cell migration, tube formation, and blocks CK2-dependent hypoxia-induced factor 1 alpha (HIF-1??) transcription in cancer cells.

More Information Supplier Page

CX-4945 (Silmitasertib) 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

CX-4945 is a potent and selective orally bioavailable small molecule inhibitor of CK2 that inhibits human umbilical vein endothelial cell migration, tube formation, and blocks CK2-dependent hypoxia-induced factor 1 alpha (HIF-1??) transcription in cancer cells.

More Information Supplier Page

CX-4945 (Silmitasertib) 10mg 10mg  | Purity Not Available

Adooq Bioscience

CX-4945 is a potent and selective orally bioavailable small molecule inhibitor of CK2 that inhibits human umbilical vein endothelial cell migration, tube formation, and blocks CK2-dependent hypoxia-induced factor 1 alpha (HIF-1??) transcription in cancer cells.

More Information Supplier Page

BMS-754807 50mg 50mg  | Purity Not Available

Adooq Bioscience

BMS-754807 is an efficacious, orally active growth factor 1 receptor/insulin receptor family-targeted kinase inhibitor that may act in combination with a wide array of established anticancer agents.

More Information Supplier Page

BMS-536924 50mg 50mg  | Purity Not Available

Adooq Bioscience

BMS-536924 is an effective inhibitor of IGF-IR, causing a reversion of an IGF-IR – mediated transformed phenotype.

More Information Supplier Page

BMS-536924 5mg 5mg  | Purity Not Available

Adooq Bioscience

BMS-536924 is an effective inhibitor of IGF-IR, causing a reversion of an IGF-IR – mediated transformed phenotype.

More Information Supplier Page